The findings showed that high expression of IRF4 was present in CCR8+ICOS+ eTregs, which further contributed to the superior suppressive activity and worse disease‐free survival and overall survival of NSCLC patients. This evidence concerns the gene IRF4 and non-small cell lung carcinoma.